Larvol Delta - ViralClear-Opens-Enrollment-with-First-Patient-Dosing-in-Phase-II-Human-Trial-of-AntiViral-MMPD-Oral-Solution-for-Treatment-of-COVID19

remdesivir - Generic mfg.

Vicromax (merimepodib) - BioSig Tech

https://www.globenewswire.com/news-release/2020/06/17/2049431/0/en/ViralClear-Opens-Enrollment-with-First-Patient-Dosing-in-Phase-II-Human-Trial-of-Anti-Viral-MMPD-Oral-Solution-for-Treatment-of-COVID-19.html

Jun 17, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next